SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 316 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $481,000 | -96.5% | 19,100 | -91.7% | 0.76% | -23.0% |
| Q2 2018 | $13,721,000 | +64.7% | 229,253 | +26.1% | 0.99% | +58.1% |
| Q1 2018 | $8,329,000 | -20.4% | 181,846 | -25.1% | 0.63% | -17.7% |
| Q2 2017 | $10,458,000 | -7.1% | 242,661 | -32.5% | 0.76% | -2.9% |
| Q1 2017 | $11,259,000 | +69.4% | 359,739 | +36.7% | 0.78% | +71.4% |
| Q4 2016 | $6,645,000 | +62.4% | 263,184 | +59.0% | 0.46% | +55.3% |
| Q3 2016 | $4,093,000 | -41.9% | 165,511 | -67.1% | 0.30% | -41.0% |
| Q3 2015 | $7,047,000 | -17.4% | 502,319 | 0.0% | 0.50% | -21.4% |
| Q2 2015 | $8,529,000 | – | 502,319 | – | 0.64% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 7,641,250 | $107,207,000 | 7.06% |
| HealthInvest Partners AB | 782,746 | $10,982,000 | 6.50% |
| KOPP INVESTMENT ADVISORS LLC | 729,960 | $10,241,000 | 5.51% |
| Murphy Michael R | 1,028,304 | $14,427,000 | 4.96% |
| Opaleye Management Inc. | 460,000 | $6,454,000 | 3.18% |
| ASHFORD CAPITAL MANAGEMENT INC | 511,244 | $7,173,000 | 1.68% |
| Bruce & Co., Inc. | 394,581 | $5,535,000 | 1.42% |
| AlphaOne Investment Services, LLC | 235,065 | $3,297,000 | 1.40% |
| Ranger Investment Management | 1,560,453 | $21,893,000 | 1.23% |
| NORTHPOINTE CAPITAL LLC | 584,753 | $8,204,000 | 1.07% |